Patent Assignment
Reel/Frame 022678/0001
Assignment of Assignor's Interest
Recorded: 2009-05-13
Pages: 9
Assignor
CUMBRE PHARMACEUTICALS INC.
Executed: 2009-04-20
Assignee
CUMBRE IP VENTURES, L.P.
3401 ARMSTRONG AVENUE, DALLAS, TEXAS, 75205
Covered Properties
(11)
High-Throughput Screening Assay for Inhibitors of Nucleic Acid Polymerases
Patent:
5,635,349 →
Application:
08/348,797 →
Rifamycin Derivatives Effective Against Drug-Resistant Microbes
Rifamycin Imino Derivatives Effective Against Drug-Resistant Microbes
Rifamycin C-11 Oxime Derivatives Effective Against Drug-Resistant Microbes
Rifamycin C-11 Oxime Cyclo Derivatives Effective Against Drug-Resistant Microbes
C-25 Carbamate Rifamycin Derivatives with Activity Against Drug-Resistant Microbes
Spiro-Rifamycin Derivatives Targeting Rna Polymerase
Rifamycin Derivatives
(R/S) Rifamycin Derivatives, Their Preparations and Pharmaceutical Compositions
Nitroheteroaryl-Containing Rifamycin Derivatives
Quinolone Carboxylic Acid-Substituted Rifamycin Derivatives
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2003
From: TULARIK INC.
To: CUMBRE INC.
Reel/Frame 014491/0871 →
Assignment of Assignor's Interest
Apr 19, 2005
From: DING, CHARLES Z.; JIN, YAFEI; LONGGOOD, JAMIE C.; MA, ZHENKUN
To: CUMBRE INC.
Reel/Frame 016103/0197 →
Assignment of Assignor's Interest
May 11, 2005
From: LI, JING; DING, CHARLES Z.; MA, ZHENKUN
To: CUMBRE INC.
Reel/Frame 015999/0328 →
Assignment of Assignor's Interest
May 11, 2005
From: LI, JING; MA, ZHENKUN
To: CUMBRE INC.
Reel/Frame 015999/0594 →
Change of Name
Jun 7, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 016309/0812 →
Merger
Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
Assignment of Assignor's Interest
Jul 20, 2005
From: MA, ZHENKUN; KIM, IN HO; LI, JING
To: CUMBRE INC.
Reel/Frame 016285/0792 →
Assignment of Assignor's Interest
Jul 28, 2005
From: COMBRINK, KEITH; HARRAN, SUSAN; DENTON, DANIEL; MA, ZHENKUN
To: CUMBRE INC.
Reel/Frame 016324/0129 →
Assignment of Assignor's Interest
Oct 5, 2005
From: MA, ZHENKUN; LI, JING; HARRAN, SUSAN; HE, YONG
To: CUMBRE INC.
Reel/Frame 016624/0031 →
Assignment of Assignor's Interest
Oct 6, 2005
From: DING, CHARLES Z.; MA, ZHENKUN; LI, JING; HARRAN, SUSAN
To: CUMBRE INC.
Reel/Frame 016625/0058 →
Assignment of Assignor's Interest
Oct 18, 2005
From: MA, ZHENKUN; JIN, YAFEI; LI, JING; DING, CHARLES Z.
To: CUMBRE INC.
Reel/Frame 016653/0278 →
Assignment of Assignor's Interest
Oct 18, 2005
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 016871/0736 →
Change of Name
Feb 14, 2007
From: CUMBRE INC.
To: CUMBRE PHARMACEUTICALS INC.
Reel/Frame 018890/0885 →
Assignment of Assignor's Interest
Jan 26, 2010
From: DING, CHARLES Z.; KIM, IN HO; WANG, JIANCHENG; JIN, YAFEI
To: CUMBRE PHARMACEUTICALS INC.
Reel/Frame 023845/0905 →
Assignment of Assignor's Interest
Jan 26, 2010
From: MA, ZHENKUN
To: GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT
Reel/Frame 023846/0026 →
Assignment of Assignor's Interest
Jan 26, 2010
From: GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT
To: CUMBRE IP VENTURES, L.P.
Reel/Frame 023846/0106 →
Assignment of Assignor's Interest
Dec 13, 2010
From: DING, CHARLES Z.; JIN, YAFEI; COMBRINK, KEITH; KIM, IN HO
To: CUMBRE PHARMACEUTICALS INC.
Reel/Frame 025476/0869 →
Assignment of Assignor's Interest
Jan 15, 2015
From: CUMBRE IP VENTURES, L.P.
To: TENNOR THERAPEUTICS LIMITED
Reel/Frame 034721/0101 →
Assignment of Assignor's Interest
Oct 26, 2021
From: TENNOR THERAPEUTICS LIMITED
To: TENNOR THERAPEUTICS (SUZHOU) LIMITED
Reel/Frame 057921/0982 →